Anti-CD4 (Clenoliximab), Chimeric Antibody

Anti-CD4 (Clenoliximab), Chimeric Antibodyis available at Gentaur for Next week Delivery.

Description: The original biosimilar is a chimeric monoclonal antibody against CD4 which acts as an immunomodulator and has been investigated for treatment of rheumatoid arthritis. CD4 acts as a coreceptor with the T-cell receptor on T lymphocytes to recognize antigens displayed by antigen presenting cells in the context of a class II MHC molecule. CD4 is also a primary viral entry point for the human immunodeficiency virus. The CD4 antigen is expressed by many cell types in addition to T lymphocytes, and is responsible for immune responses against pathogens and other stimuli.

Immunogen Sequence:Human CD4

Target Alternative Name:CD4 Antigen; T-Cell Surface Antigen T4/Leu-3; IMD79; OKT4D

Species Reactivities:Human

Tag Line:Chimeric monoclonal antibody to target human CD4

Formulation:In PBS, pH 7.5

Purification: /

Application:/

Positive Control:/

Application And Usages:/

Handling:The antibody solution should be gently mixed before use.